Clinical Trial Update: Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia [NA]

View source ↗

Summary

This clinical trial update reports on a completed study comparing nebulized amikacin to intravenous amikacin for nosocomial pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nosocomial Pneumonia

Drugs mentioned

• Amikacin (intravenous) (amikacin)
• Amikacin (nebulized) (amikacin)

Snippet

Sponsor: National Heart Institute, Egypt | Conditions: Pneumonia | NA | Status: COMPLETED